Cargando…

Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer

AIM: To assess real-world outcomes and prognostic factors of non-metastatic inflammatory breast cancer according to immunohistochemistry (IHC)-based subtype and treatment regimen. METHODS: An institutional retrospective analysis of patients treated with neoadjuvant systemic treatment (NAST) for stag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhar, Cvetka Grašič, Borštnar, Simona, Gazić, Barbara, Matos, Erika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300582/ https://www.ncbi.nlm.nih.gov/pubmed/36740512 http://dx.doi.org/10.1016/j.breast.2023.01.011

Ejemplares similares

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Human epidermal growth factor receptor 2-positive microinvasive breast carcinoma with a highly aggressive course: a case report
por: Grasic Kuhar, Cvetka, et al.
Publicado: (2014)

Effectiveness of adjuvant trastuzumab in daily clinical practice
por: Matos, Erika, et al.
Publicado: (2014)

The Possible Role of Anti- and Protumor-Infiltrating Lymphocytes in Pathologic Complete Response in Early Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy
por: Geršak, Klara, et al.
Publicado: (2023)

Digital ischemic events related to gemcitabine: Report of two cases and a systematic review
por: Kuhar, Cvetka Grasic, et al.
Publicado: (2010)

Biomarkers for Outcome in Metastatic Melanoma in First Line Treatment with Immune Checkpoint Inhibitors
por: Mesti, Tanja, et al.
Publicado: (2023)

The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma
por: Miceska, Simona, et al.
Publicado: (2023)

Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
por: Besic, Nikola, et al.
Publicado: (2021)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Changes in the quality of life of early breast cancer patients and comparison with the normative Slovenian population
por: Grasic Kuhar, Cvetka, et al.
Publicado: (2023)

The Biology and Clinical Potential of Circulating Tumor Cells
por: Lozar, Taja, et al.
Publicado: (2019)

Morphological Features of Breast Cancer Circulating Tumor Cells in Blood After Physical and Biological Type of Isolation
por: Jesenko, Tanja, et al.
Publicado: (2021)

Mobile App for Symptom Management and Associated Quality of Life During Systemic Treatment in Early Stage Breast Cancer: Nonrandomized Controlled Prospective Cohort Study
por: Grašič Kuhar, Cvetka, et al.
Publicado: (2020)

Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer
por: Grašič Kuhar, Cvetka, et al.
Publicado: (2023)

Neuroendocrine Carcinoma of the Larynx and Pharynx: A Clinical and Histopathological Study
por: Strojan, Primož, et al.
Publicado: (2021)

Early Cardiotoxicity after Adjuvant Concomitant Treatment with Radiotherapy and Trastuzumab in Patients with Breast Cancer
por: Marinko, Tanja, et al.
Publicado: (2018)

Preclinical and Clinical Evaluation of Magnetic-Activated Cell Separation Technology for CTC Isolation in Breast Cancer
por: Lozar, Taja, et al.
Publicado: (2020)

Boils in the Axillæ
Publicado: (1889)

Atopy--a favourable prognostic factor for survival in Hodgkin's disease.
por: Amlot, P. L., et al.
Publicado: (1983)

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: results of the CECOG LaVie trial
por: Thallinger, Christiane, et al.
Publicado: (2016)

Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience
por: Petric, Rok, et al.
Publicado: (2014)

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
por: Santonja, Angela, et al.
Publicado: (2018)

Anatomical variations of the axilla
por: Soares, Emerson Wander Silva
Publicado: (2014)

Tuberculous Glands in Axilla
por: Bhushan, K.
Publicado: (1920)

On the Retention of Hair in the Axilla
por: Martin, A. Wyndham
Publicado: (1884)

Malignant Hidradenocarcinoma of the Axilla
por: Johnson, Evan P, et al.
Publicado: (2020)

Sebaceous carcinoma of the axilla
por: Siguan, Anthony Paolo T, et al.
Publicado: (2020)

Ultrasound imaging of the axilla
por: Cocco, Giulio, et al.
Publicado: (2023)

Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
por: Liao, Hong-Ye, et al.
Publicado: (2018)

Chest Wall Fibromatosis in the Axilla
por: Lee, Seung-Hyun, et al.
Publicado: (2012)

Management of the Positive Axilla in 2017
por: Ozmen, Tolga, et al.
Publicado: (2017)

Conserving the axilla in breast cancer
por: Jozsa, Felix, et al.
Publicado: (2020)

Phthiriasis Pubis with Involvement of Axillae
por: Luo, Ze-Yu, et al.
Publicado: (2023)

Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes
por: Araujo, Jhajaira M., et al.
Publicado: (2022)

Early platelet elevation after complete remission as a prognostic marker of favourable outcomes in favourable‐ and intermediate‐risk acute myeloid leukaemia: A retrospective study
por: Wen, Xiaoling, et al.
Publicado: (2022)

Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications
por: Liu, Shenting, et al.
Publicado: (2023)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2au4j6kmhbbs2malisolcfuh65